These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 33995632)
1. Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT. Ye J; Qi L; Liang J; Zong K; Liu W; Li R; Feng R; Zhai W J Cancer; 2021; 12(12):3548-3557. PubMed ID: 33995632 [TBL] [Abstract][Full Text] [Related]
2. Liensinine induces gallbladder cancer apoptosis and G2/M arrest by inhibiting ZFX-induced PI3K/AKT pathway. Shen Y; Bian R; Li Y; Gao Y; Liu Y; Xu Y; Song X; Zhang Y Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):607-614. PubMed ID: 31074773 [TBL] [Abstract][Full Text] [Related]
3. Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation. Zhai T; Zhang X; Hei Z; Jin L; Han C; Ko AT; Yu X; Wang J Front Pharmacol; 2021; 12():628621. PubMed ID: 33679411 [TBL] [Abstract][Full Text] [Related]
4. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway. Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055 [TBL] [Abstract][Full Text] [Related]
5. Oridonin inhibits hypoxia-induced epithelial-mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer. Chen K; Ye J; Qi L; Liao Y; Li R; Song S; Zhou C; Feng R; Zhai W Anticancer Drugs; 2019 Oct; 30(9):925-932. PubMed ID: 31517732 [TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor-D promotes growth, lymphangiogenesis and lymphatic metastasis in gallbladder cancer. Lin W; Jiang L; Chen Y; She F; Han S; Zhu J; Zhou L; Tang N; Wang X; Li X Cancer Lett; 2012 Jan; 314(2):127-36. PubMed ID: 22071224 [TBL] [Abstract][Full Text] [Related]
7. SNORA71A Downregulation Enhances Gemcitabine Sensitivity in Gallbladder Cancer Cells by Inducing Ferroptosis Through Inhibiting the AKT/NRF2/GPX4 Pathway. Qin Y; Zhou Y; Wu H; Lei H; Ding T; Shen X; Li J DNA Cell Biol; 2024 Nov; 43(11):559-569. PubMed ID: 39403747 [TBL] [Abstract][Full Text] [Related]
8. SLC25A22 promotes proliferation and metastasis by activating MAPK/ERK pathway in gallbladder cancer. Du P; Liang H; Fu X; Wu P; Wang C; Chen H; Zheng B; Zhang J; Hu S; Zeng R; Liang B; Fang L Cancer Cell Int; 2019; 19():33. PubMed ID: 30814911 [TBL] [Abstract][Full Text] [Related]
9. Parthenolide induces gallbladder cancer cell apoptosis via MAPK signalling. Obulkasim H; Aji G; Abudoula A; Liu Y; Duan S Ann Med Surg (Lond); 2024 Apr; 86(4):1956-1966. PubMed ID: 38576937 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro. Fan YZ; Fu JY; Zhao ZM; Chen CQ Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171 [TBL] [Abstract][Full Text] [Related]
11. Oxymatrine induces apoptosis and inhibits invasion in Gallbladder carcinoma via PTEN/PI3K/AKT pathway. Qian L; Li X; Ye P; Wang G; Dai W; Liu Y; Gao Q; Shen G Cytotechnology; 2018 Feb; 70(1):83-94. PubMed ID: 29170841 [TBL] [Abstract][Full Text] [Related]
12. Sinensetin flavone exhibits potent anticancer activity against drug-resistant human gallbladder adenocarcinoma cells by targeting PTEN/PI3K/AKT signalling pathway, induces cellular apoptosis and inhibits cell migration and invasion. Huang B; Zhai M; Qin A; Wu J; Jiang X; Qiao Z J BUON; 2020; 25(2):1251-1256. PubMed ID: 32521933 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis. Qin Y; Chu B; Gong W; Wang J; Tang Z; Shen J; Quan Z J Gastroenterol Hepatol; 2014 May; 29(5):964-72. PubMed ID: 24329682 [TBL] [Abstract][Full Text] [Related]
14. Bmi-1 in gallbladder carcinoma: Clinicopathology and mechanism of regulation of human gallbladder carcinoma proliferation. Jiao K; Jiang W; Zhao C; Su D; Zhang H Oncol Lett; 2019 Aug; 18(2):1365-1371. PubMed ID: 31423199 [TBL] [Abstract][Full Text] [Related]
15. SP/NK-1R promotes gallbladder cancer cell proliferation and migration. Deng XT; Tang SM; Wu PY; Li QP; Ge XX; Xu BM; Wang HS; Miao L J Cell Mol Med; 2019 Dec; 23(12):7961-7973. PubMed ID: 30903649 [TBL] [Abstract][Full Text] [Related]
16. Effect of Tian C; Zhang B; Ge C Oncol Lett; 2020 Sep; 20(3):2677-2688. PubMed ID: 32782584 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of BRD4 inhibits gallbladder cancer proliferation and metastasis and induces apoptosis via PI3K/AKT pathway. Hao J; Yang Z; Wang L; Zhang Y; Shu Y; Jiang L; Hu Y; Lv W; Dong P; Liu Y Int J Oncol; 2017 Sep; 51(3):823-831. PubMed ID: 28766687 [TBL] [Abstract][Full Text] [Related]
18. Combination of celecoxib and PD184161 exerts synergistic inhibitory effects on gallbladder cancer cell proliferation. Deng M; Qin Y; Chen X; Li D; Wang Q; Zheng H; Gu L; Deng C; Xue Y; Zhu D; Wang Q; Wang J Oncol Lett; 2017 May; 13(5):3850-3858. PubMed ID: 28521485 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2. Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515 [TBL] [Abstract][Full Text] [Related]
20. Wogonin, an active ingredient of Chinese herb medicine Scutellaria baicalensis, inhibits the mobility and invasion of human gallbladder carcinoma GBC-SD cells by inducing the expression of maspin. Dong P; Zhang Y; Gu J; Wu W; Li M; Yang J; Zhang L; Lu J; Mu J; Chen L; Li S; Wang J; Liu Y J Ethnopharmacol; 2011 Oct; 137(3):1373-80. PubMed ID: 21855619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]